Intellia Therapeutics, Inc.
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −0.80 USD per share, beating the −0.80 USD estimate by −0.09%. Revenue for the same period reached 7.66 M USD, despite the estimate of 12.98 M USD. For the next quarter, analysts expect −0.80 USD in earnings per share and 10.23 M USD in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise